Market Trends of Asia-Pacific Single-use Medical Device Reprocessing Industry
This section covers the major market trends shaping the APAC Single Use Medical Device Reprocessing Market according to our research experts:
Sequential Compression Sleeves Segment is Expected to Witness Growth Over the Forecast Period
Compression sleeves are inflatable ones that connect to an air pump to augment blood flow in a limb for blood clot prevention. These devices will record a large share owing to the increasing number of interventions and the consequent economic load demand for assessing SUDs' reuse. Japan does not have any regulations for the reprocessing of single-use medical devices. Therefore, regulatory authorities, such as the MHLW (Japan), in collaboration with the FDA, are focusing on generating new medical instrument reprocessing guidelines for Japan. Therefore all these factors are expected to drive the overall market.
Sequential compression sleeves are used widely worldwide due to the high burden of diseases such as deep vein thrombosis and pulmonary embolism. These diseases will further increase over the years. As per the study published in March 2021 by the Indian Journal of Vascular and Endovascular Surgery, there were 518,111 admissions, with a VTE incidence of 19.49/10,000 cases. Males contributed to 55% of patients in this study. Acute deep-vein thrombosis (DVT) (less than 14 days of presentation) contributed to 66% of the patients. The age group between 41 and 60 years had the maximum incidence of DVT of 43.9%. Hence, the class II device segment will grow due to the rising medical device demand.
China is Expected to Witness Growth Over the Forecast Period
China holds a significant share in the single-use medical device reprocessing market and is expected to show a similar trend over the forecast period, mainly due to the increasing cost of reusable medical devices and the rising prevalence of cardiovascular diseases in the region.
Increasing cases of cardiovascular diseases and related surgical procedures are the primary growth factors. CVD is the leading cause of healthcare burden in China. The prevalence and incidence of the disease are increasing with time. The research article published in April 2022 by the International Journal of Public Health mentioned that CVD is one of the significant healthcare burdens in China. And as per the article, currently, 290 million people suffering from cardiac disorders (13 million), Stroke, coronary heart disease (11 million), rheumatic heart disease (2.5 million), heart failure (4.5), congenital heart disease (2 million), pulmonary heart disease (5 million), and hypertension (245 million) in China. Also, the source mentioned above that out of the total mortality related to CVD, 40% occurs in China alone. The prevalence of cardiac diseases generates a need for cardiovascular device monitoring and diagnostic devices. This high prevalence of diseases requiring class I and II devices will significantly boost the market's growth.
Thus, due to the factors mentioned above, the studied market is expected to grow significantly during the study period.
